The NovaFlow Stent Biliary System is an advanced, minimally invasive solution designed to restore and maintain bile duct patency in patients with benign or malignant biliary strictures. Engineered with robust materials, precision deployment, and secure anchoring mechanisms, NovaFlow helps streamline biliary decompression under endoscopic or fluoroscopic guidance—promoting efficient care and improved patient outcomes.
Key Features & Design
High-Strength Stent Construction
Metal or Hybrid Materials (model-dependent): Offers consistent radial force to prop open the constricted duct while accommodating ductal peristalsis.
Biocompatible Coatings (if applicable): Minimizes friction or potential ingrowth, supporting better stent patency and easy retrieval when indicated.
Precision Delivery System
Low-Profile Catheter: Facilitates navigation through the ampulla and ductal system, reducing trauma to surrounding tissues.
Controlled Deployment: A user-friendly mechanism ensures progressive release of the stent, limiting misplacement or sudden expansion.
Secure Anchoring
Segmented Design (if applicable): Provides stable tissue contact points, decreasing migration risk in high-flow or dynamic duct segments.
Anti-Reflux / Anti-Migration Options (some models): May include flared ends or specialty coatings for long-term stent retention.
Radiopaque Markers
Fluoroscopic Guidance: Clear marker bands enhance visualization under X-ray, ensuring accurate stent placement across the stricture.
Real-Time Feedback: Helps operators confirm final stent positioning and verify full expansion.
Clinical Applications & Benefits
Benign & Malignant Biliary Strictures
Cholangiocarcinoma, pancreatic or ampullary neoplasms, sclerosing cholangitis, or post-surgical strictures: NovaFlow stents facilitate drainage and symptomatic relief of obstructive jaundice.
Palliation: Reduces pruritus, cholestasis, and infection risks in advanced disease.
Versatile Deployment
Endoscopic Retrograde Cholangiopancreatography (ERCP): Stent introduction and release under endoscopic and/or fluoroscopic guidance, streamlining procedural flow.
Percutaneous Access (PTBD): If endoscopic approaches are unfeasible, the stent can be advanced through a percutaneous track (depending on system design).
Patient Quality of Life
Prompt Symptom Relief: Decompressing the biliary tract alleviates pain, pruritus, and hepatic dysfunction, restoring normal activities faster.
Reduced Procedure Frequency: Reliable stent patency and low migration rates diminish the need for multiple re-interventions.
Enhanced Safety
Controlled Delivery: Minimizes ductal trauma or false passage creation, crucial in anatomically challenging or fibrotic ducts.
Stable Drainage: Intelligent design avoids kinking or stent collapse, preserving ongoing patency.
